Skip to Content

Aplenzin Approval History

  • FDA approved: Yes (First approved April 23rd, 2008)
  • Brand name: Aplenzin
  • Generic name: bupropion hydrobromide
  • Dosage form: Extended-Release Tablets
  • Previous name: BVF-033
  • Company: Biovail Corporation
  • Treatment for: Depression, Major Depressive Disorder

Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Development History and FDA Approval Process for Aplenzin

Apr 24, 2008Approval Biovail Receives FDA Approval for Aplenzin (BVF-033)

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.